Nancy L. Kuntz

Northwestern University — United States

Medicine · Health Sciences

49h-index12.8kcitations203works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurogenetic and Muscular Disorders Research(69), Muscle Physiology and Disorders(60), RNA modifications and cancer(20), Multiple Sclerosis Research Studies(16), Peripheral Neuropathies and Disorders(16)

Publications199 total

Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children
Steroids·2025Open Access
Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients.
Scientific Reports·2025· 1 citedOpen Access
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy
Expert Review of Neurotherapeutics·2025
Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy
Journal of Clinical Investigation·2025· 2 citedOpen Access
470PClinical development program for efgartigimod in juvenile generalized myasthenia gravis
Neuromuscular Disorders·2025
426PEfficacy and safety of apitegromab in patients aged 13-21 years with type 2 or 3 spinal muscular atrophy: outcomes from the SAPPHIRE phase 3 trial
Neuromuscular Disorders·2025
Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study
Therapeutic Advances in Rare Disease·2025Open Access
425PRGX-202, an investigational gene therapy for the treatment of Duchenne muscular dystrophy: interim clinical data
Neuromuscular Disorders·2025
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial
The Lancet Neurology·2025· 13 citedOpen Access
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series
BMC Neurology·2025· 3 citedOpen Access
Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States
Neurology·2025· 2 citedOpen Access
Study Design of Subcutaneous Efgartigimod PH20 in Juvenile Generalized Myasthenia Gravis (P7-6.009)
Neurology·2025
Outcomes of early‐treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study
Muscle & Nerve·2024· 10 citedOpen Access
180P Interim results from RESPOND: a study of nusinersen in children with spinal muscular atrophy (SMA) previously treated with onasemnogene abeparvovec (OA)
Neuromuscular Disorders·2024· 2 cited
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies
Journal of Multidisciplinary Healthcare·2024· 4 citedOpen Access
Access to novel therapies for Duchenne muscular dystrophy—Insights from expert treating physicians
Annals of the Child Neurology Society·2024· 4 citedOpen Access
Spinal Muscular Atrophy Update in Best Practices
Neurology Clinical Practice·2024· 31 citedOpen Access
Prevalence of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Individuals With Dystrophinopathy at a Tertiary Care Center in Chicago
Pediatric Neurology·2024· 1 cited
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy
Neurology·2024· 54 citedOpen Access
Use of the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) in Spinal Muscular Atrophy
Journal of Clinical Medicine·2024· 1 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Richard S. Finkel(22), Craig M. McDonald(19), Anne M. Connolly(15), Perry B. Shieh(15), Jean K. Mah(14), M. Tulinius(12), Monique M. Ryan(12), Basil T. Darras(11), Paula R. Clemens(11), John Day(10), Yoram Nevo(10), Richard Webster(10), Michela Guglieri(10), Eric P. Hoffman(9), Janbernd Kirschner(8), Russell J. Butterfield(8), Edward C. Smith(8), Diana Castro(8), Volker Straub(8), Erik Henricson(7)